Status:
COMPLETED
Reduction of Anterior Shoulder Dislocation Facilitated by Inhaled Low Dose Methoxyflurane
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Shoulder Dislocation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This pilot study will test the feasibility of doing a definitive study to ascertain whether reduction of shoulder dislocation can be safely and effectively facilitated by a patient controlled inhalati...
Detailed Description
Anterior shoulder dislocation, in which the head of the humerus (cup) comes out of its position in the glenoid fossa (saucer), to lie anterior and below its proper position, is a common emergency depa...
Eligibility Criteria
Inclusion
- Anterior dislocation not complicated by fracture (pre-reduction x-rays will be done at the discretion of the emergency physician)
- No neurological or vascular injury
- Patients greater than or equal to 18 years of age
- Patients able to understand the nature of the study and give written informed consent
- Patient is able to follow all study requirements and procedures and complete all questionnaires
Exclusion
- Previous shoulder surgery on the affected side
- Associated fracture or secondary significant injury
- Previous in-hospital reduction attempt for the current dislocation
- Open wound or infection in the vicinity of the joint
- Uncorrectable altered level of consciousness, to be defined by the attending clinician as a Glasgow-Coma Scale of less than 15, due to any cause, including head injury, drugs, or alcohol
- History of clinically significant renal impairment
- History of liver dysfunction after previous methoxyflurane use or other halogenated anesthetics
- Hypersensitivity to methoxyflurane or other halogenated anesthetics
- Known or genetically susceptible to malignant hyperthermia or a history of severe adverse reactions in either patient or relatives
- Clinically evident hemodynamic instability
- Clinically evident respiratory impairment
- Has received methoxyflurane within the past 3 months
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03853954
Start Date
June 1 2019
End Date
September 9 2022
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NSHA
Halifax, Nova Scotia, Canada, B3H3A7